Diffuse Toxic Goiter Hyperthyroid with Atrial Fibrillation in Type 2 Diabetes Patient
DOI:
https://doi.org/10.66266/inajemd.v1i2.21Keywords:
Goiter, hyperthyroid, atrial fibrillation, type 2 diabetesAbstract
Goiter is an enlargement of the thyroid gland which can occur in euthyroid, hyperthyroid, or hypothyroid. Hyperthyroidism can cause symptoms, such as palpitations, fatigue, sleep disturbances, weight loss, and heat intolerance. There are various complications and symptoms of hyperthyroidism, one of which is cardiac arrhythmia. Thyroid dysfunction can coexist with type 2 diabetes, so special attention is needed. Male, 43 years old, complaining of palpitations in the chest since 2 days ago. Complaints were accompanied by weakness, hand tremors, and lack of appetite. Patient also complained there was a lump in the neck that moved when swallowing since 5 months ago. Patient has a history of type 2 diabetes and regularly takes metformin. Physical examination found diffuse enlargement of the thyroid gland, soft consistency, indistinct borders and irregular heart rhythm. Electrocardiography showed atrial fibrillation. Ultrasound examination revealed bilateral diffuse goiter. Free T4 result is elevated. Therapy given is infusion, methimazole, beta-blockers, digoxin, and metformin. Thyroid hormones have significant effects on the heart, which include increasing resting pulse rate, blood volume, stroke volume, cardiac muscle contractility, and ejection fraction. Thyroid also causes sinus rhythm disturbances. Early thyroid treatment has a better prognosis for improvement. Treatment of hyperthyroidism can affect the condition of diabetes, so monitoring blood sugar is necessary. Early diagnosis and prompt treatment of hyperthyroidism can resolve complaints and prevent complications. Thyroxine concentrations higher than normal are more at risk of experiencing atrial fibrillation. Hyperthyroidism can occur together with type 2 diabetes so it needs special attention.
Downloads
References
1. Can AS, Rehman A. Goiter. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 JanTreasure Island, FL: StatPearls; 2023.
2. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug 27;388(10047):906-918.
3. Goichot B, Caron P, Landron F, Bouée S. Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters. Clin Endocrinol (Oxf). 2016 Mar;84(3):445-51.
4. Sharma A, Stan MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019; 94(6):1048-1064.
5. Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Physician. 2016 ;93(5):363-70.
6. Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res. 2013;2013:390534. Ahmed SS, Mohammed AA. Effects of thyroid dysfunction on hematological parameters: Case controlled study. Ann Med Surg (Lond). 2020; 57:52-55.
7. Ahmad M, Reddy S, Barkhane Z, Elmadi J, Satish Kumar L, Pugalenthi LS. Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review. Cureus. 2022; 14(4):e24378.
8. Chaker L, Heeringa J, Dehghan A, Medici M, Visser WE, Baumgartner C, Hofman A, Rodondi N, Peeters RP, Franco OH. Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study. J Clin Endocrinol Metab. 2015; 100(10):3718-24.
9. Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014; 26(6):296-309.
10. Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):60-63.
11. Kalra S, Aggarwal S, Khandelwal D. Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management. Diabetes Ther. 2019;10(6):2035-2044.
12. N Nishi M. Diabetes mellitus and thyroid diseases. Diabetol Int. 2018;9(2):108-112.
13. Ray S, Ghosh S. Thyroid disorders and diabetes mellitus: Double trouble. J of Diab Res and Therap. 2016; 2(1).
14. Liu X, Liu J, Fan L, Shi B. Erythrocytosis associated with hyperthyroidism: A rare case report and clinical study of possible mechanism. Endocron Res 2015; 40(4):177–80.
15. Souresho H, Mgerian M, Havican S, Suniega E, Gambrill C. A Practical Approach to Polycythemia in the Outpatient Setting and Its Importance. Cureus. 2021;13(11):e19368.
16. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.
17. Meng X, Xu S, Chen G, Derwahl M, Liu C. Metformin and thyroid disease. J Endocrinol. 2017;233(1):R43-R51.
18. Anil C, Kut A, Atesagaoglu B, Nar A, Bascil Tutuncu N, Gursoy A. Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study. Med Princ Pract. 2016;25(3):233-6.
19. Tseng CH. Thyroid cancer risk is not increased in diabetic patients. PLoS One. 2012;7(12):e53096.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).
